Fund HoldingsBML Capital Management, LLC

Total Portfolio Value
$132.18M
Total Bought
$18.36M
Total Sold
$13.76M
Net Transaction
+$4.60M
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
THIRD HARMONIC BIO INC3,824,4173,824,417013,27120,76715.71%+7,496
ATEA PHARMACEUTICALS INC7,609,8127,609,812022,75327,39520.73%+4,642
INSTIL BIO INC416,720534,899+118,1797,23411,1428.43%+3,908
ALUMIS INC49,6271,210,415+1,160,7883053,6312.75%+3,327
TESLA INC(TSLA)(Put)0200+20001,654+1,654
MILESTONE PHARMACEUTICALS IN1,136,0911,136,09109092,2041.67%+1,295
PMV PHARMACEUTICALS INC3,747,6125,000,000+1,252,3884,0855,3004.01%+1,215
KEZAR LIFE SCIENCES INC
COM NEW
408,138635,183+227,0451,9922,9092.20%+917
IKENA ONCOLOGY INC3,710,8034,030,102+319,2994,7505,4004.09%+651
ELEVATION ONCOLOGY INC5,890,9345,890,434-5001,5262,1621.64%+636
CONNECT BIOPHARMA HLDGS LTD2,093,2321,821,558-271,6741,1511,7851.35%+634
ESSA PHARMA INC4,221,5464,221,54606,6707,1775.43%+507
CORVUS PHARMACEUTICALS INC(CRVS)0118,766+118,76604750.36%+475
ORAMED PHARMACEUTICALS INC3,020,7483,083,253+62,5056,4646,9375.25%+473
HILLEVAX INC20,76091,913+71,153301830.14%+153
LAVA THERAPEUTICS NV1,960,6101,970,610+10,0002,4902,6011.97%+111
LISATA THERAPEUTICS INC216,853209,814-7,0395106080.46%+99
ATHIRA PHARMA INC3,200,6673,230,667+30,0009129760.74%+64
VERRICA PHARMACEUTICALS INC174,651174,651077930.07%+15
ACHILLES THERAPEUTICS PLC3,804,9210-3,804,921000
TURNSTONE BIOLOGICS CORP1,103,3861,103,38604523960.30%-56
VISTAGEN THERAPEUTICS INC150,000150,00003753000.23%-75
NEXTCURE INC273,5360-273,5361310-131
ASTROTECH CORP220,410220,41001,4281,2730.96%-155
SAGE THERAPEUTICS INC135,0950-135,0951,0740-1,074
ACLARIS THERAPEUTICS INC(ACRS)14,250,00014,250,000021,80320,23515.31%-1,567
WHITEHAWK THERAPEUTICS INC1,890,2450-1,890,2453,3650-3,365
ADVERUM BIOTECHNOLOGIES INC2,742,3173,057,526+315,20911,9846,5744.97%-5,410
AN2 THERAPEUTICS INC5,749,4320-5,749,4327,8190-7,819
Page 1 of 1